GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Eagle Pharmaceuticals
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital drugs. Its stock price depends on its success in obtaining approvals and generic competition.
Share prices of companies in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of injectable drugs for oncology and critical care. We've categorized it under "Breast Cancer." The chart below shows how the market values companies that improve existing treatments.
Broad Market Index - GURU.Markets
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing injectable drugs with improved performance. Its focus on this niche makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Eagle fits into the overall dynamics.
Change in the price of a company, segment, and market as a whole per day
EGRX - Daily change in the company's share price Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc.'s daily price change reflects the high volatility inherent in pharmaceutical companies. This metric measures its sensitivity to sales of its hospital drugs and regulatory announcements.
Daily change in the price of a set of shares in a market segment - Breast cancer
Eagle Pharmaceuticals is a specialty pharmaceutical company developing injectable medications for critical care and oncology. The chart below shows volatility in the pharmaceutical sector, allowing us to assess how EGRX's stock performance aligns with industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Eagle Pharmaceuticals is a pharmaceutical company specializing in hospital drugs. Its stock price is driven by sales volumes, competition, and development progress. These factors create fluctuations that contribute to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Eagle Pharmaceuticals
Eagle Pharmaceuticals' year-over-year performance tells the story of its unique business model. Its market capitalization over the past 12 months reflects its success in developing improved versions of existing hospital drugs. Its strategy is not to invent new products, but to improve existing ones, allowing it to occupy profitable niches.
Annual dynamics of market capitalization of the market segment - Breast cancer
Eagle, a commercial pharmaceutical company, specializes in injectables. This chart shows how its sales performance, competition, and portfolio expansion efforts impact its performance in the pharmaceutical sector, where it is a niche player.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Eagle Pharmaceuticals, with its focus on injectables, demonstrates how to successfully operate in the Big Pharma niche. Its ability to stay ahead of the market depends on developing improved versions of existing drugs and protecting its intellectual property.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Eagle Pharmaceuticals
Eagle Pharma is a pharmaceutical company specializing in injectables. Its monthly performance reflects both sales of its existing products and expectations for new developments and patent litigation.
Monthly dynamics of market capitalization of the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital medications. Its model is based on risk reduction compared to the creation of new molecules. The dynamics of the pharmaceutical sector provide a general backdrop against which Eagle seeks opportunities to improve the safety, efficacy, and usability of existing drugs.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of injectable drugs. Its business depends on success in R&D and partnerships. The broader market chart serves as a backdrop to assess how its strategy of improving existing drugs and introducing new products has impacted its performance.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Eagle Pharmaceuticals
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing injectable medications. Its weekly stock price is driven by news of product approvals and patent disputes.
Weekly dynamics of market capitalization of the market segment - Breast cancer
Eagle Pharmaceuticals develops and commercializes injectables, often improved versions of existing medications. Its success depends on FDA approvals and a patent strategy. The chart will show whether Eagle's share price performance is driven by its unique products or a general investor reaction to developments in the pharmaceutical sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Eagle Pharmaceuticals is a pharmaceutical company. Its shares move on news about clinical trials and patent disputes. This chart clearly demonstrates how much its performance is driven by internal events rather than general market trends.
Market capitalization of the company, segment and market as a whole
EGRX - Market capitalization of the company Eagle Pharmaceuticals
Eagle Pharmaceuticals' market capitalization chart reflects its business model, which focuses on developing improved versions of existing injectable drugs. Its market valuation reflects how investors weigh its success in commercializing its products against the risks associated with patent disputes and generic competition.
EGRX - Share of the company's market capitalization Eagle Pharmaceuticals within the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in improving existing drugs. Its market share isn't as large as that of blockbuster developers, but it is a significant player in its niche of injectables. The chart reflects the success of its strategy and the stability of its product portfolio revenue.
Market capitalization of the market segment - Breast cancer
The graph below shows the overall value of the pharmaceutical sector. Eagle Pharmaceuticals occupies a niche in this sector, developing improved versions of existing hospital drugs. Its market strategy is not to create new molecules, but to improve the safety or usability of proven drugs, which is a less risky business model.
Market capitalization of all companies included in a broad market index - GURU.Markets
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectable medications. Its market capitalization reflects its focus on this market. The chart below shows the economic weight of companies operating in the hospital drug market.
Book value capitalization of the company, segment and market as a whole
EGRX - Book value capitalization of the company Eagle Pharmaceuticals
Eagle Pharma's book value is derived from its intellectual property and commercial drugs, primarily hospital injectables with improved performance. The chart tells the story of a pharmaceutical company that builds its business not on discovering new molecules, but on improving existing ones, which requires smaller, but still significant, investments.
EGRX - Share of the company's book capitalization Eagle Pharmaceuticals within the market segment - Breast cancer
Eagle Pharmaceuticals develops injectable drugs with improved properties. The chart shows its share of actual R&D assets. These are its laboratories where new drug formulations are created, which constitute its core intellectual and material assets.
Market segment balance sheet capitalization - Breast cancer
Eagle Pharmaceuticals develops and commercializes injectable drugs. Their model often involves improving existing drugs. The book value chart reflects the value of their laboratories and manufacturing partnerships, but their primary value lies in their intellectual property.
Book value of all companies included in the broad market index - GURU.Markets
Eagle Pharmaceuticals' balance sheet includes laboratories and partner manufacturing facilities for creating improved versions of existing hospital drugs. The chart shows how the company built its capital for its pharmaceutical development.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Eagle Pharmaceuticals
Eagle Pharmaceuticals specializes in developing improved versions of existing drugs. Its value lies in its patents and regulatory approvals. The chart shows how the market values its drug portfolio and its ability to win patent disputes. The premium to the balance sheet represents the price paid for its intellectual property and future cash flows.
Market to book capitalization ratio in a market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing injectable drugs (e.g., those with easier administration). Its value is determined by its technologies and patents. The chart shows how the market values its product portfolio and its ability to extend the life of existing drugs.
Market to book capitalization ratio for the market as a whole
Eagle Pharmaceuticals develops improved versions of existing hospital drugs. Its value lies in its patents and regulatory approvals. This metric demonstrates how much the market values its ability to create products with improved performance, which generates a premium to its book value, which consists primarily of cash and inventory.
Debts of the company, segment and market as a whole
EGRX - Company debts Eagle Pharmaceuticals
Eagle Pharmaceuticals specializes in developing improved versions of existing hospital drugs. This chart shows how the company manages its capital. Revenue from already approved products is used to fund the development of new candidates and to protect its intellectual property in litigation.
Market segment debts - Breast cancer
Eagle Pharmaceuticals specializes in developing improved versions of existing hospital drugs. This strategy reduces risks compared to developing new molecules, but still requires investment in clinical research. This chart shows how the company uses its balance sheet to fund its development pipeline.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Eagle Pharmaceuticals
Eagle Pharmaceuticals is a pharmaceutical company specializing in injectables. This chart shows its financial structure. For a company whose success depends on several key products, a strong balance sheet is essential to protect against patent collapses and invest in new developments.
Market segment debt to market segment book capitalization - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing injectable drugs. This chart shows the debt burden in the biotech sector. It helps understand how the company finances its clinical trials and legal processes to bring its products to market.
Debt to book value of all companies in the market
Eagle Pharmaceuticals is a specialty pharmaceutical company that frequently improves existing drugs. This model may be less risky than developing a new drug from scratch, but it still requires investment. This chart of total market debt helps assess how the company finances its development and how conservative its financial strategy is.
P/E of the company, segment and market as a whole
P/E - Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops improved versions of existing injectable medications, offering dosage or safety advantages. This chart shows how investors view its reformulation model. The trend depends on the approval and commercial success of its improved products.
P/E of the market segment - Breast cancer
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectable drugs, primarily for oncology and critical care. Its strategy is to improve existing drugs. This chart shows the average valuation for the oncology sector, reflecting how investors value companies with a low-risk, yet stable, revenue model.
P/E of the market as a whole
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs. Its valuation depends on its ability to secure approvals for its products and successfully commercialize them. General market sentiment, reflected in this chart, has little impact on its business, which is determined by the specifics of the pharmaceutical market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company developing improved versions of existing injectable medications. This chart reflects its expected future revenue, which depends on the success of its development pipeline, patent protection, and ability to compete with brand-name and generic medications.
%20P%2FE%20Eagle%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Eagle-Pharmaceuticals&v=1772513907003 "Chart of the company's future (projected) P/E Eagle Pharmaceuticals")
Future (projected) P/E of the market segment - Breast cancer
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectable drugs with improved performance. This chart shows general expectations for the pharmaceutical sector. The EGRX's position relative to the average reflects market opinion on their strategy to improve existing drugs and the commercial success of their portfolio.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Breast%20cancer&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Breast-cancer&v=1772513907025 "Future (projected) P/E graph of the market segment - Breast cancer")
Future (projected) P/E of the market as a whole
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectable drugs for oncology and critical care. The company frequently improves existing medications, making them more convenient or safer. This chart of general market expectations provides a framework for evaluating pharmaceutical companies with a niche strategy and a clear market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513907073 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes improved versions of existing injectable medications. The revenue graph shows how successfully the company is bringing its products to market, offering advantages over brand-name medications, such as easier administration.
Profit of companies in the market segment - Breast cancer
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectable therapies with improved performance, including for cancer treatment. This chart shows overall profitability in the breast cancer treatment sector, reflecting investment interest and scientific progress in creating new and improved therapeutic options for patients.
Overall market profit
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital drugs. Its success depends on its ability to create products with clinical advantages and obtain regulatory approval. The overall economic situation, reflected in this chart, has less of an impact on its business than on consumer goods companies.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company developing improved versions of existing hospital medications. Its profitability depends on successful development and commercialization. This chart shows analyst expectations for future sales of its product portfolio, including oncology and critical care medications.
%20profit%20of%20the%20company%20Eagle%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Eagle-Pharmaceuticals&v=1772513907083 "Graph of future (projected) profit of the company Eagle Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs, often for use in oncology and critical care. This strategy helps reduce development risks. This chart shows forecasts for the entire pharmaceutical sector, helping to assess how successful Eagle's business model is within the broader pharmaceutical industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Breast%20cancer&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Breast-cancer&v=1772513907099 "Graph of future (predicted) profits of companies in a market segment - Breast cancer")
Future (predicted) profit of the market as a whole
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs. Its success depends on regulatory approval and its ability to compete with original medications. General economic cycles, reflected in this chart, have only an indirect impact on its business.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513907100 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Eagle Pharmaceuticals
Eagle Pharmaceuticals specializes in developing improved versions of existing hospital drugs. This chart shows how the market views its strategy of "smart" developments that offer advantages over original medications. The dynamics reflect the success of its product commercialization and the potential of its development pipeline.
P/S market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing injectable drugs. Revenue is generated from sales of these products. This pharmaceutical sector chart helps assess how investors view Eagle's drug improvement strategy and its ability to secure regulatory approval.
P/S of the market as a whole
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing improved versions of existing hospital medications. Its products often offer advantages in dosage or administration route. This market revenue valuation chart helps understand how investors view this business model, based on incremental innovation.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes injectables, often improved versions of existing medications, for use in hospitals. This chart shows how the market views the future sales of its products. It reflects their expectations for commercial success and product life cycles.
%20P%2FS%20Eagle%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Eagle-Pharmaceuticals&v=1772513907164 "The graph of the company's future (projected) P/S Eagle Pharmaceuticals")
Future (projected) P/S of the market segment - Breast cancer
Eagle Pharmaceuticals is a specialty pharmaceutical company that develops improved versions of existing injectable medications, often with more convenient dosing or fewer side effects. The company's valuation reflects its ability to successfully obtain approval for these modified products and compete in the hospital drug market.
%20P%2FS%20market%20segment%20graph%20-%20Breast%20cancer&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Breast-cancer&v=1772513907171 "Future (projected) P/S market segment graph - Breast cancer")
Future (projected) P/S of the market as a whole
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs. Its business model is based on innovations in drug delivery. In the overall revenue growth picture illustrated by the chart, Eagle represents a niche segment of the pharmaceutical industry.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513907177 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company. This chart shows its revenue, which is generated through sales of several injectable medications used in oncology and critical care, as well as royalties and license fees from partners.
Sales of companies in the market segment - Breast cancer
Eagle Pharmaceuticals (EGRX) is a specialty pharmaceutical company that develops and commercializes injectable medications, primarily for oncology and critical care. This metric reflects revenue in the oncology sector. Eagle improves existing medications, making them more convenient and safe to use, creating value for the healthcare system.
Overall market sales
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital medications. Its success depends on its ability to create products with clinical advantages. This overall economic climate impacts hospital budgets. In a stable economic environment, they may be more open to introducing new, albeit more expensive, drugs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Eagle Pharmaceuticals
Eagle Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of injectable drugs with improved performance. Its revenue depends on sales of existing products and the success of new developments. This chart reflects analyst revenue forecasts, which are an assessment of its product portfolio and ability to bring improved versions of its drugs to market.
%20sales%20of%20the%20company%20Eagle%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Eagle-Pharmaceuticals&v=1772513907230 "Schedule of future (projected) sales of the company Eagle Pharmaceuticals")
Future (projected) sales of companies in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in the development of improved injectable medications for critical care and oncology. This chart segments projected sales by their key products. This allows analysts to assess which of their drugs will be the primary revenue drivers.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Breast%20cancer&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Breast-cancer&v=1772513907235 "Schedule of future (projected) sales of companies in the market segment - Breast cancer")
Future (projected) sales of the market as a whole
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital medications. Its business model is based on innovation in drug formulations. This chart reflects general trends in healthcare, and Eagle's success depends on its ability to create products that are more convenient to use and safer for patients.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513907250 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company that improves existing hospital drugs, making them more convenient or safer. Profitability depends on the success of these modifications and their market acceptance. The chart shows how the company, by focusing on incremental innovation, generates profits in the pharmaceutical industry.
Market segment marginality - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of injectable drugs with improved performance. This chart shows the company's profitability. Success depends on its ability to secure approval for its improved versions of existing drugs and successfully commercialize them.
Market marginality as a whole
Eagle Pharmaceuticals is a specialty pharmaceutical company developing improved versions of existing drugs. Its success depends on its ability to demonstrate the benefits of its products. This overall profitability chart reflects the state of the healthcare system. Financially stable hospitals are more willing to adopt new formulas if they improve efficiency.
Employees in the company, segment and market as a whole
Number of employees in the company Eagle Pharmaceuticals
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable medications for hospitals, often improving existing drugs. This graphic shows the team working on developing products with improved safety or ease of use for critical situations.
Share of the company's employees Eagle Pharmaceuticals within the market segment - Breast cancer
Eagle Pharmaceuticals is a specialized pharmaceutical company that improves existing hospital drugs. Its model requires a team of scientists to develop new formulas and a sales team to work with hospitals. This chart illustrates the scale of personnel required to develop and market products in its niche pharmaceutical market.
Number of employees in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs. This chart, showing activity in the breast cancer treatment sector, highlights one of their key areas. For Eagle, growth in this area signifies a large market where their innovative formulas can offer advantages in convenience or safety.
Number of employees in the market as a whole
Eagle Pharmaceuticals develops and commercializes injectable medications, often improving existing drugs. The company's success depends on the acceptance of its products by the healthcare system. The growth in overall employment, reflected in this chart, supports hospital and clinic funding through insurance premiums, allowing them to purchase Eagle's modern and effective medications.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals (EGRX) specializes in developing improved versions of existing hospital drugs (e.g., oncology). Their model is based on R&D focused on reformulation and strong B2B marketing. This metric reflects the market's value of their patents for "improvements" and their market share relative to their relatively small workforce.
%20of%20the%20company%20Eagle%20Pharmaceuticals%20(EGRX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Eagle-Pharmaceuticals-EGRX&v=1772513907457 "Chart of market capitalization per employee (in thousands of dollars) of the company Eagle Pharmaceuticals (EGRX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing drugs. Its value lies in its patents for new formulas. This metric reflects the market's assessment of its ability to create high-value-added products through its research team.
%20by%20market%20segment%20-%20Breast%20cancer&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Breast-cancer&v=1772513907461 "Market capitalization per employee (in thousands of dollars) by market segment - Breast cancer")
Market capitalization per employee (in thousands of dollars) for the overall market
Eagle Pharmaceuticals is a specialized pharmaceutical company that improves existing drugs, making them more convenient or safer. This model is lower-risk than developing them from scratch. This chart for Eagle illustrates how this strategy can generate significant market value per employee through the intelligent use of existing knowledge.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513907490 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals is a specialty pharma company. Their model isn't about inventing new molecules, but rather improving existing ones, such as creating more convenient delivery forms, which extends patent protection. This chart shows how this business model, based on R&D and regulatory expertise, can be highly profitable.
%20Chart%20Eagle%20Pharmaceuticals%20(EGRX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Eagle-Pharmaceuticals-EGRX&v=1772513907507 "Company Profit Per Employee (in thousands of dollars) Chart Eagle Pharmaceuticals (EGRX)")
Profit per employee (in thousands of dollars) in the market segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing improved versions of existing hospital medications. The success of this model depends on the effectiveness of its R&D and commercial teams. This metric demonstrates how the company translates scientific improvements into financial gains by occupying niches in the injectable drug market.
%20in%20the%20market%20segment%20-%20Breast%20cancer&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Breast-cancer&v=1772513907527 "Chart of profit per employee (in thousands of dollars) in the market segment - Breast cancer")
Profit per employee (in thousands of dollars) for the market as a whole
Eagle Pharmaceuticals is a specialized pharmaceutical company that develops "improved" versions of existing drugs (for example, for oncology), making them more convenient or safer. This chart measures the average profit per employee across the economy. It provides investors with context: how effective a pharmaceutical business, even one focused on "improvement" rather than discovery, is in terms of employee productivity.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513907546 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals is a specialty pharmaceutical company developing improved versions of existing injectable medications. Revenue per employee reflects the commercial success of its proprietary products. The graph shows how the company generates revenue by offering hospitals more convenient and safer forms of established medications.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Eagle-Pharmaceuticals-EGRX&v=1772513907570 "Sales chart per company employee Eagle Pharmaceuticals (EGRX)")
Sales per employee in the market segment - Breast cancer
Eagle Pharmaceuticals (EGRX) is a specialty pharmaceutical company developing injectable drugs with improved performance (e.g., for oncology). This chart shows the average revenue per employee in the segment. It helps assess how effectively Eagle generates sales for its drugs, including recently approved ones.
Sales per employee for the market as a whole
Eagle Pharmaceuticals (EGRX) is a specialty pharmaceutical company that improves existing hospital medications (for example, by creating ready-to-use formulations) and develops new ones. This metric reflects how effectively their R&D and sales teams generate revenue from this portfolio of niche, yet high-margin injectable medications.
Short shares by company, segment and market as a whole
Shares shorted by company Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals (EGRX) is a company specializing in developing improved versions of existing hospital drugs. Its business model is vulnerable to patent collapses. This chart shows short interest. The rise in bearish bets may be related to concerns about the loss of exclusivity on key drugs and doubts about the pipeline's ability to offset these losses. (349)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Eagle-Pharmaceuticals-EGRX&v=1772513907700 "Short Shares Chart for the Company Eagle Pharmaceuticals (EGRX)")
Shares shorted by market segment - Breast cancer
Eagle Pharmaceuticals (EGRX) is a specialty pharmaceutical company developing injectable drugs (including oncology) with improved performance. The chart below shows the overall short position in the specialty pharmaceutical sector. It shows how concerned investors are about generic competition and regulatory pressure.
Shares shorted by the overall market
Eagle Pharma is a "specialized" pharmaceutical company that frequently improves existing drugs. This chart illustrates the overall market pessimism. Investors fear that EGRX's key products will face generic competition, and that during a crisis, the healthcare system will put downward pressure on the prices of generic drugs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals (EGRX) is a specialty pharmaceutical company that reformulates existing drugs (for example, in oncology) to improve their performance. This indicator measures trend strength. It shows when the stock is "overheated" (above 70) on FDA approval news or "oversold" (below 30) on patent dispute news.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Eagle-Pharmaceuticals-EGRX&v=1772513907758 "RSI 14 indicator chart for the company's stock Eagle Pharmaceuticals (EGRX)")
RSI 14 Market Segment - Breast cancer
Eagle Pharmaceuticals is a pharmaceutical company specializing in developing injectable drugs (including oncology drugs) with improved performance (e.g., ready-to-use). This chart measures the collective excitement in the oncology biotech sector. It helps differentiate the EGRX movement from the overall industry trend.
RSI 14 for the overall market
For Eagle Pharmaceuticals, a biotech in the R&D stage, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is turned off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast EGRX (Eagle Pharmaceuticals)
Eagle Pharmaceuticals isn't a company that invents new molecules, but rather "improves" existing ones: making injections faster or safer (e.g., Bendeka, Ryanodex). This chart shows the average price target from analysts, reflecting their view on sales of the current portfolio and the risks associated with patent expirations and R&D.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-EGRX-Eagle-Pharmaceuticals&v=1772513907787 "A chart showing analyst consensus forecasts for the expected stock price. EGRX (Eagle Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price EGRX (Eagle Pharmaceuticals)
Eagle Pharma is a drug "improver." The company takes existing hospital drugs and "improves" them (for example, making them ready for injection). This chart measures the gap between the current price and the consensus target price. It shows how confident experts are in their R&D portfolio and their ability to compete with generics.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-EGRX-Eagle-Pharmaceuticals&v=1772513907847 "A chart showing the difference between the consensus forecast and the actual stock price. EGRX (Eagle Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Breast cancer
Eagle Pharmaceuticals is a specialized pharmaceutical company that "improves" existing hospital drugs (for example, by changing their formulas for easier administration). This chart shows the general expectations of analysts in the pharmaceutical sector (oncology). It reflects whether experts believe the strategy of "improving" old drugs is profitable.
Analysts' consensus forecast for the overall market share price
Eagle Pharmaceuticals is a specialty pharmaceutical company that doesn't invent, but rather "improves" existing hospital drugs (for example, by changing their formulas for convenience). This chart shows overall market sentiment. For Eagle, which operates in the "defensive" healthcare sector, overall optimism is important for funding, but their business is valued for its stability, as they work with approved molecules.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Eagle Pharmaceuticals
Eagle Pharma (EGRX) is an improver for hospital pharma. Their specialty isn't R&D from scratch, but rather improvements (505(b)(2)) on older, established injectables (e.g., chemotherapy), making them safer or more convenient (RTU). This chart is a summary indicator of their patent model. It weighs their (high-margin) sales of old hits against their (critical) R&D race to find the next big thing.
AKIMA Market Segment Index - Breast cancer
Eagle Pharmaceuticals is a drug refiner. They don't invent new molecules, but rather take existing ones (for example, for breast cancer treatment) and improve their formulas (for example, making them ready for administration). This chart compares their composite index to the sector, showing how far their formula strategy is ahead of R&D.
The AKIM Index for the overall market
Eagle Pharmaceuticals is a specialty pharmaceutical company developing injectables for intensive care and oncology. This chart, which reflects the market average, provides a macro backdrop. It helps assess how EGRX, which faces competition and legal issues, compares to overall economic trends.
